The laboratory has been established in 1993 by prof. Angelo Rosolen and is part of the Laboratory of Pediatric Hematology Oncology directed by Prof. Giuseppe Basso.
The laboratory works closely with the physicians that follows children with different types of solid tumors at the Pediatric Hematology Oncology Division in Padova. Over the years it has developed a particular interest in diagnostics and basic and translational research for children with soft sarcoma and other rare tumors. The main activities are:
- To provide the necessary molecular biology investigations to support the diagnosis of solid tumor. The laboratory is the reference laboratory of the AIEOP soft tissue sarcoma working group and offer these services at a national and international level.
- To collect, handling and store biological samples from patients with solid tumors treated in the Pediatric Hematology Oncology Division of Padova. Sample are also collected from all children with soft tissue sarcoma enrolled by Italian Centres in the national and international protocol dedicated to children with soft tissue sarcomas.
- To promote research projects dedicated to study the biological characteristics of pediatric soft tissue sarcomas and biomarkers that can have a direct clinical application
Selected PublicationsStachowicz-Stencel T, Orbach D, Brecht I, Schneider D, Bien E, Synakiewicz A, Rod J, Ferrari A, Cecchetto G, Bisogno G. 2015. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT). Eur J Cancer, 51(16):2444-52
Bisogno G, Brennan B, Orbach D, Stachowicz-Stencel T, Cecchetto G, Indolfi P, Bien E, Ferrari A, Dommange-Romero F. 2014. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur J Cancer, 50(1):178-84
Ferrari A, De Salvo GL, Dall'Igna P, Meazza C, De Leonardis F, Manzitti C, De Ioris MA, Casanova M, Carli M, Bisogno G. 2012. Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma. Eur J Cancer, 48(18):3448-55
Ferrari S, Ruggieri P, Cefalo G, Tamburini A, Capanna R, Fagioli F, Comandone A, Bertulli R, Bisogno G, Palmerini E, Alberghini M, Parafioriti A, Linari A, Picci P, Bacci G.. 2012. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. J Clin Oncol, 30(17):2112-8
Bisogno G, Soloni P, Conte M, Podda M, Ferrari A, Garaventa A, Luksch R, Cecchetto G.. 2012. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees.. BMC Cancer, 25;12:117
Corso Stati Uniti, 4
Phone: +39 049 9640139
Fax: +39 049 9640101